These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7756061)

  • 1. Role of acadesine in clinical myocardial protection.
    Alkhulaifi AM; Pugsley WB
    Br Heart J; 1995 Apr; 73(4):304-5. PubMed ID: 7756061
    [No Abstract]   [Full Text] [Related]  

  • 2. Acadesine: a unique cardioprotective agent for myocardial ischemia.
    Nawarskas JJ
    Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
    Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
    Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
    Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
    J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving preconditioning from bench to bedside.
    Kloner RA
    J Am Coll Cardiol; 2006 Jul; 48(1):215-6. PubMed ID: 16814670
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Mangano DT
    JAMA; 1997 Jan 22-29; 277(4):325-32. PubMed ID: 9002496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
    Mullane K
    Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine hearts.
    Vinten-Johansen J; Nakanishi K; Zhao ZQ; McGee DS; Tan P
    Circulation; 1993 Nov; 88(5 Pt 2):II350-8. PubMed ID: 8222178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase: the guardian of cardiac energy status.
    Hardie DG
    J Clin Invest; 2004 Aug; 114(4):465-8. PubMed ID: 15314681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acadesine on myocardial ischaemia in patients with coronary artery disease.
    de Jonge R; Macleod DC; Suryapranata H; van Es GA; Friedman J; Serruys PW; de Jong JW
    Eur J Pharmacol; 1997 Oct; 337(1):41-4. PubMed ID: 9389379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.
    Holdright DR; Sparrow JL; Wright CL; Steiner J; Fox KM
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):193-7. PubMed ID: 7918131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.
    Leung JM; Stanley T; Mathew J; Curling P; Barash P; Salmenpera M; Reves JG; Hollenberg M; Mangano DT
    Anesth Analg; 1994 Mar; 78(3):420-34. PubMed ID: 7818622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Anesthesiology; 1995 Oct; 83(4):658-73. PubMed ID: 7574044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
    Zhao ZQ; Williams MW; Sato H; Hudspeth DA; McGee DS; Vinten-Johansen J; Van Wylen DG
    Cardiovasc Res; 1995 Apr; 29(4):495-505. PubMed ID: 7796443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group.
    Menasché P; Jamieson WR; Flameng W; Davies MK
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1096-106. PubMed ID: 7475138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
    Drew BG; Kingwell BA
    Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
    Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
    J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.
    Engler RL
    J Card Surg; 1994 May; 9(3 Suppl):482-92. PubMed ID: 8069041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acadesine improves tolerance to ischemic injury in rat cardiac myocytes.
    Gruver EJ; Toupin D; Smith TW; Marsh JD
    J Mol Cell Cardiol; 1994 Sep; 26(9):1187-95. PubMed ID: 7815461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unorthodox and orthodox: the therapeutic role of acadesine after traumatic injury and sepsis.
    Unkle DW
    Crit Care Med; 1999 Mar; 27(3):468-9. PubMed ID: 10199518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.